Collaboration Will Bring Enhanced Guest Experiences and New Revenue Streams to Hotels, Spas & Wellness Clinics VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) — Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF), the leader in bio-streaming wellness technology, has announced a strategic partnership with Gharieni Group, a leading international manufacturer of premium-quality spa tables, treatment beds and equipment. Under the terms of the agreement, Gharieni becomes the exclusive distributor of Hapbee’s Enterprise Solutions for Spa and Wellness across Europe and the Middle East. As global wellness continues its rapid expansion—now valued at over USD $5 trillion—hospitality operators are seeking turnkey solutions that deliver improved guest experiences and new revenue streams. This partnership directly...

CHICAGO, April 03, 2025 (GLOBE NEWSWIRE) — TalentAlly, a Professional Diversity Network, Inc. (NASDAQ: IPDN) company, and a leading inclusive recruitment solution and job board in the United States, announces a recognition as the finalist for two prestigious Digital Job Advertising Excellence (DJAx) Awards: the Technology Innovation Award and Best Customer Success Team Award in the niche job board category. Hosted by Job Boards Connect, the DJAx Awards honor companies driving the future of job advertising through innovation, exceptional service, and measurable impact. Advancing AI-Powered Hiring Solutions The Technology Innovation Award recognizes organizations that effectively leverage technology to enhance the recruitment process for both job seekers and employers. With 83% of companies projected to use AI in hiring by the end...

The Management Board of Joint Stock Company ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ (unified reg. No. 40003013295, legal address: ‘Kalnabeites 8’, Sigulda, Sigulda area, LV-2150) announces that regular shareholders’ meeting of the Joint Stock Company ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ will take place on April 25, 2025 at 10:00 a.m. at ‘Kalnabeites 8’, Sigulda, Sigulda area. Agenda:Reports of the management board and the supervisory board. Approval of Annual report for the year 2024. Decision making on the dispose of profit. Discharging the members of the management board, the members of the supervisory board and the auditor from responsibility for action in the year of account and resigning from bringing claims against them. Election of the auditor and confirmation of the remuneration for the...

Draft agenda and draft decisions for the Annual General Meeting of Telia Lietuva, AB (hereinafter ‘the Company’ or ‘Telia Lietuva’) shareholders to be held on 28 April 2025 proposed by the Board of the Company: 1. Information of the Company’s auditor. Taken for the information. 2. Approval of the annual financial statements of the Company for the year 2024 and presentation of the annual report of the Company for the year 2024. Draft decision:1) To approve the audited annual financial statements of the Company for the year 2024.2) The annual report of the Company for the year 2024, prepared by the Company, assessed by the auditors and approved by the Board, was presented. 3. Allocation of the Company’s profit for the year 2024. Draft decision: To allocate the Company’s profit for the year 2024 in line with the proposal for profit allocation...

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it will report results for the quarter ended March 31, 2025, after the closing of the Nasdaq Global Select Market on Monday, May 12, 2025. The Company will also host a conference call on Tuesday, May 13, 2025, at 8:30 a.m. Eastern Time. All interested parties are welcome to participate in the conference call by dialing (800) 225-9448 approximately 5-10 minutes prior to the call; international callers should dial (203) 518-9708. Participants should reference either MidCap Financial Investment Corporation Earnings or Conference ID: MFIC0513 when prompted. A simultaneous webcast of the conference call will be available to the public on a listen-only basis and can be accessed through the Events Calendar...

The Annual General Meeting of Telia Lietuva, AB (code 121215434, registered address: Saltoniškių str. 7A, Vilnius, Lithuania) Shareholders will be held in Telia Lietuva, AB headquarters, Saltoniškių str. 7A, Vilnius, Lithuania, at 13.00 on 28 April 2025. Registration will take place from 12.00 till 12.30. The meeting is convened by the initiative of the Board and following the decision of the Board adopted on 2 April 2025. The General Meeting of Shareholders’ accounting day is 21 April 2025. The shareholders’ proprietary rights accounting day is 13 May 2025. Proposed Agenda:1. Presentation by the Company’s auditor.2. Approval of the Company’s annual financial statements for the year 2024 and presentation of the Company’s annual report for the year 2024.3. Allocation of the Company’s profit for the year 2024.4. Approval of the Company’s...

Comes on the heels of company’s rebranding and new strategic direction, advancing its lead program in ovarian cancer CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it has entered into a securities purchase agreement with accredited investors for the private placement of approximately 69.3 million shares of common stock (or pre-funded warrants to purchase shares of common stock), at a purchase price of $0.1046 per share for an aggregate purchase price of approximately $7,250,000, assuming the Company receives stockholder approval. “These are very exciting times at Ernexa, as we advance therapeutic innovation in cell therapy for the benefit of patients with cancer and autoimmune...

TAMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to provide this annual update from its Chief Executive Officer, Surendra Ajjarapu, to its stockholders. This time last year, Scienture Holdings, Inc. (f.k.a. TRxADE Health, Inc.). was focused on health services IT assets and operations aimed at digitalizing the retail pharmacy experience. The primary operations were conducted through our wholly-owned subsidiary, Integra Pharma Solutions, LLC (“IPS”), which is a licensed pharmaceutical wholesaler and sells brand, generic and...